For citations:

Rudakova A.V. Cost-effectiveness of paricalcitol in hemodialysis patients with secondary hyperparathyroidism. Nephrology and Dialysis. 2018;20(4):378-384. (In Russ.) https://doi.org/10.28996/2618-9801-2018-4-378-384